SEC 13F Intelligence

Sivik Global Healthcare LLC / CELG

Sivik Global Healthcare LLC’s Celgene Corp Position

Does Sivik Global Healthcare LLC own Celgene Corp (CELG)? Not currently — the last reported position was 50.0K shares worth $5M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2019
Shares
50.0K
% of Portfolio
+2.51%
Quarters Held
3
position exited

Position History CELG

Reported value by quarter
Q1 ’19: $6MQ1 ’19Q2 ’19: $6MQ2 ’19Q3 ’19: $5MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 201950.0K$5M+2.51%
Q2 201960.0K$6M+1.34%
Q1 201960.0K$6M+2.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of CELG.